[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:pancreatic-adenocarcinoma:mtap-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Pancreatic Adenocarcinoma","MTAP Gene",5,[8,16,23,30,36],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06914128","A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:19:08.862440Z","2026-07-05T05:32:16.701684Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07277413","A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors",[20],"Phase 1","2026-08-26T02:16:01.910993Z","2026-07-05T05:32:16.679197Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT07492680","A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and\u002For Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)",[27],"Phase 2","2026-08-26T02:17:47.813245Z","2026-06-16T05:54:07.939792Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT05245500","Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion",[20],"2026-08-26T02:18:27.904411Z","2026-05-05T02:43:26.709142Z",{"nct_id":37,"title":38,"phases":39,"status":40,"updated_at":41,"content_modified":42},"NCT06188702","S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:02:32.170340Z","2026-05-05T02:43:28.020362Z"]